Search Results 251-260 of 16208 for GLP-1 agonist

  1. A Study to Assess Maternal and Fetal Outcomes in Pregnancy with Type 1 Diabetes Mellitus and Controls - Mayo Clinic

    A Study to Assess Maternal and Fetal Outcomes in Pregnancy with Type 1 Diabetes Mellitus and Controls · Overview · Participation eligibility · Participating Mayo ...

  2. Glutamine (oral route) - Side effects & dosage - Mayo Clinic

    Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. Back to top ...

  3. Lamotrigine (oral route) - Side effects & dosage - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Atazanavir; Azathioprine ...

  4. Agalsidase beta (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is given through an IV catheter that is placed in one of your veins. ... You may report side effects to the FDA at 1-800-FDA-1088. Back to top. Drug ...

  5. Puberty blockers for transgender and gender-diverse youth - Mayo Clinic

    The medicines most often used for this purpose are called gonadotropin-releasing hormone (GnRH) analogues. Here's a summary of their possible benefits, side ...

  6. Extracellular Vesicle Cargo During Type 1 Diabetes Progression - Mayo Clinic

    This study aims to identify an early stage biomarker for type 1 diabetes. In vitro evidence identified a significant enrichment of the chemokine CXCL10 in β- ...

  7. Heart attack - Doctors and departments - Mayo Clinic

    Heart & Blood Health Discussions. ldjones99 · Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri, Dec ...

  8. Impact of Non-glucose Signals on Glycemic Control in Patients With Type 1 Diabetes - Mayo Clinic

    This clinical trial will identify exercise-related and emotional stress related effects on glycemic control in patients with type 1 diabetes using sensor- ...

  9. Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes (REGENT-1-US) - Mayo Clinic

    Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes (REGENT-1-US) · Share · Facebook · Twitter.

  10. Publications - Iasmina M. Craici, M.D. - Mayo Clinic

    Safety and Efficacy of GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus with Advanced and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.